Umlando wethu

 

 

 
2016

•Isungulwe e-Hangzhou, e-China

 
2017

•Ithole ukugunyazwa kokulawula{0}}kwemikhiqizo yokuqala yokuxilonga ngokushesha yezilwane ezifuywayo.

 
2018

• Inwetshiwe yaba izimakethe zamazwe ngamazwe -ngezixazululo zokuxilonga.

 
2019

• Kwethulwe ngokusemthethweni imikhiqizo yokuhlola ngokushesha imfuyo

 
2021-2022

•Isikhungo se-R&D esiqediwe, uMnyango we-QA/QC, kanye nesikhungo sokukhiqiza esiqinisekisiwe se-GMP{0}.

 
2022.3

• Uzuze isitifiketi se-ISO 9001

• Igunyazwe njengeLabhorethri ye-Biosafety Level II.

 
2022.4

• Kuqaliswe uhlelo lwe-R&D lokuxilongwa kwezilwane ezifuywayo zangaphandle.

•Usungule umugqa wokuqala wokuhlola we-Cryptosporidium antigen emhlabeni wezilwane ezihuquzelayo.

 
2022.5

• Waba yilungu le-China Veterinary Medical Association

 
2022.12

• Imikhiqizo yebhrendi ye-VD esatshalaliswa emazweni angu-40+.

• Secured >Isabelo semakethe esingu-60% ezifundeni ezibalulekile.

 
2023.2

•Yasungulwa i-CHENGDU EVEGEN BIOTECH CO., LTD ukuze kuqiniswe ukukhiqizwa nokusetshenziswa kwezinto.

 
2023.6

• Ujoyine i-China Veterinary Drug Association.

 
2023.7

• Ithole izitifiketi ze-ISO 14001 ne-ISO 45001.

• Inkampani ephethwe yi-Chengdu ithole ilayisensi yomuthi wezilwane we-GSP.

 
2023.9

• Uthole ilungelo lobunikazi ku-Feline Herpesvirus Type 1 (FHV-1)

• Uthole ilungelo lobunikazi nge-Equine Infectious Anemia Virus

 
2024.10

• Uthole ilungelo lobunikazi ekuhlolweni kwe-Leishmania Antibody

 
2025.1

• Uthole ilungelo lobunikazi kuCanine Leishmania

 
2025.3

• Uthole ilungelo lobunikazi ku-anti-ETEC K99 antibody eyodwa